Clinical utility of complementary measurements standard tumor markers and cytokines in patients with cervical cancer
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 6
Abstract
We aimed to relate the levels of serum tumour markers (CEA, CA 125, CYFRA 21.1) and cytokines (IL-6, VEGF) in cervical cancer patients to the clinicopathologic features of the disease and to estimate the value of these measurements as complementary to the standard tumour marker (SCC) assessment. The study comprised 200 untreated patients with confirmed cervical cancer. All the examined serum markers and cytokines were found to correlate with the clinical stage. CA 125 concentrations were found significantly higher in adenocarcinoma of the uterine cervix, as compared to squamous cell carcinoma. Circulating CA 125 in cervical adenocarcinoma proved to have a better diagnostic sensitivity than CEA. The best diagnostic sensitivity was shown for simultaneous measurements of SCC and IL-6. The use of other tumour markers and cytokines assessed complementary to SCC in the sera of patients with cervical cancer of different histopathological type was also studied. In patients with histologically confirmed squamous cell carcinoma the highest increase of diagnostic sensitivity was achieved by SCC measurements along with IL-6. In patients with adenocarcinoma, cytokine and CA 125 measurements complementary to SCC produced the best diagnostic sensitivity. Conclusions: In patients with cervical carcinoma, serum IL-6 measurements complementary to SCC, the standard tumour marker assessed in cervical carcinoma patients, improve diagnostic sensitivity. This is especially important and useful for patients in the early clinical stages. In patients with cervical adenocarcinoma, CA 125 presents a better diagnostic value than CEA.
Authors and Affiliations
Beata Kotowicz, Maria Kowalska, Małgorzata Fuksiewicz, Janina Kamińska
Keywords
Related Articles
- EP ID EP118359
- DOI -
- Views 86
- Downloads 0
Badania przesiewowe w raku jelita grubego
Rak jelita grubego jest jednym z najpoważniejszych problemów zdrowotnych w Polsce. Rocznie rozpoznaje się ok. 11 tys. nowych zachorowań (w krajach Unii Europejskiej – 220 tys.); liczba zgonów z powodu tej choroby sięga z...
Zastosowanie połączenia pozytonowej tomografii emisyjnej z tomografią komputerową w rozpoznaniu wznowy i ocenie leczenia imatinibem nowotworu podścieliskowego przewodu pokarmowego – opis przypadku
Połączenie pozytonowej tomografii emisyjnej (positron emission tomography – PET) z tomografią komputerową (computed tomography – CT) (PET/CT) z użyciem F-18-fluorodeoksyglukozy (FDG) należy do najnowszych metod obrazow...
Wznowa biochemiczna po radioterapii raka stercza
Wznowa biochemiczna 5 lat po teleradioterapii lub brachyterapii występuje u 5–20 proc. pacjentów z I grupy prognostycznej oraz u 30–60 proc. chorych z II i III grupy prognostycznej. Wyniki napromieniania oceniane są na p...
Sprawozdanie z 17th International Symposium Supportive Care in Cancer
Results of examination of early melanoma detection carried out on citizens of Poznań
Incidence and mortality of melanoma in Poland and in other countries have risen steeply. Tumor depth remains the best predictor of patient survival. However, physical examination is still associated with an increase in...